Literature DB >> 3307569

Lung function in prematurely delivered rabbits treated with a synthetic surfactant.

W H Tooley, J A Clements, K Muramatsu, C L Brown, M A Schlueter.   

Abstract

We treated prematurely delivered rabbit pups with the synthetic surfactant that has been named Exosurf. By weight, Exosurf is 61.8% dipalmitoylphosphatidylcholine, 6.8% hexadecanol, 4.6% tyloxapol, and 26.7% NaCl. This simple mixture, suspended at 15 mg lipid X ml-1 water, has appropriate in vitro characteristics for a lung surfactant substitute. As determined by static pressure volume relationships performed after 30 min ventilation, lungs treated with Exosurf accepted significantly more gas at maximal inflation (36 versus 15 ml X kg-1 body weight) and had significantly greater volumes during deflation that did saline-treated control lungs; lungs treated with natural rabbit surfactant (SAM) had significantly larger volumes at maximal inflation (65 versus 35 ml X kg-1) and during deflation than did the Exosurf-treated lungs. After 30 min of ventilation with oxygen and fixation at 10 cm H2O pressure, the ratio of air space to tissue space was determined by a point-counting technique, and mean linear intercepts were measured for air spaces. Exosurf-treated lungs were intermediate between SAM and saline-treated lungs in both measurements. With positive pressure ventilation to maintain a tidal volume of 6.5 to 7.5 ml X kg-1, total compliance was significantly greater and inspiratory pressure significantly lower in both SAM- and Exosurf-treated animals than in saline-treated control animals, although the lungs of the SAM-treated animals were more compliant than the lungs of animals treated with Exosurf. During the first minute of positive pressure ventilation, lungs treated with SAM or Exosurf expanded equally rapidly, both expanding more rapidly than the saline-treated lungs.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3307569     DOI: 10.1164/ajrccm/136.3.651

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  15 in total

Review 1.  Lung surfactants for neonatal respiratory distress syndrome: animal-derived or synthetic agents?

Authors:  Gautham K Suresh; Roger F Soll
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

2.  Targeted delivery of liquid microvolumes into the lung.

Authors:  Jinho Kim; John D O'Neill; N Valerio Dorrello; Matthew Bacchetta; Gordana Vunjak-Novakovic
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-31       Impact factor: 11.205

Review 3.  The adult respiratory distress syndrome.

Authors:  N F Voelkel
Journal:  Klin Wochenschr       Date:  1989-06-01

Review 4.  Exogenous surfactant treatments for neonatal respiratory distress syndrome and their potential role in the adult respiratory distress syndrome.

Authors:  T A Merritt; M Hallman; R Spragg; G P Heldt; N Gilliard
Journal:  Drugs       Date:  1989-10       Impact factor: 9.546

5.  Lung volume and pulmonary blood flow measurements following exogenous surfactant.

Authors:  J Alexander; A D Milner
Journal:  Eur J Pediatr       Date:  1995-05       Impact factor: 3.183

6.  Appropriate surfactant usage in 1996.

Authors:  R F Soll
Journal:  Eur J Pediatr       Date:  1996-08       Impact factor: 3.183

Review 7.  Colfosceril palmitate. A review of the therapeutic efficacy and clinical tolerability of a synthetic surfactant preparation (Exosurf Neonatal) in neonatal respiratory distress syndrome.

Authors:  K L Dechant; D Faulds
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

8.  Comparison of surface properties and physiological effects of a synthetic and a natural surfactant in preterm rabbits.

Authors:  J D Corcoran; P Berggren; B Sun; H L Halliday; B Robertson; T Curstedt
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-11       Impact factor: 5.747

9.  Effect of nebulized bovine surfactant for experimental otitis media with effusion.

Authors:  Chul Ho Jang; Yong Bum Cho; Seung Eun Oh; Jeong Uk Choi; Haekyun Park; Cheol Hee Choi
Journal:  Clin Exp Otorhinolaryngol       Date:  2010-03-30       Impact factor: 3.372

Review 10.  Prophylactic protein free synthetic surfactant for preventing morbidity and mortality in preterm infants.

Authors:  Roger Soll; Eren Ozek
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.